PetMed Express (NASDAQ:PETS) Share Price Crosses Above 200-Day Moving Average - What's Next?

PetMed Express, Inc. (NASDAQ:PETS - Get Free Report) shares crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.38 and traded as high as $4.53. PetMed Express shares last traded at $4.49, with a volume of 204,635 shares.

Wall Street Analyst Weigh In

Separately, StockNews.com downgraded shares of PetMed Express from a "buy" rating to a "hold" rating in a report on Tuesday, February 11th.

PetMed Express Stock Up 2.8 %

The stock has a market capitalization of $91.30 million, a PE ratio of 442.44 and a beta of 0.70. The firm has a 50 day moving average price of $4.81 and a 200 day moving average price of $4.40.

PetMed Express (NASDAQ:PETS - Get Free Report) last released its quarterly earnings results on Monday, February 10th. The company reported ($0.03) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. On average, equities analysts forecast that PetMed Express, Inc. will post 0.19 earnings per share for the current fiscal year.

Remove Ads

Insider Activity

In other PetMed Express news, Director Leslie C.G. Campbell purchased 15,000 shares of the firm's stock in a transaction that occurred on Wednesday, December 4th. The stock was bought at an average cost of $5.38 per share, with a total value of $80,700.00. Following the completion of the transaction, the director now owns 70,000 shares of the company's stock, valued at $376,600. The trade was a 27.27 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. 1.10% of the stock is currently owned by corporate insiders.

Institutional Trading of PetMed Express

Institutional investors and hedge funds have recently modified their holdings of the business. Independent Advisor Alliance purchased a new stake in shares of PetMed Express during the 3rd quarter valued at $106,000. R Squared Ltd purchased a new stake in PetMed Express during the fourth quarter worth about $31,000. Virtu Financial LLC purchased a new stake in PetMed Express during the fourth quarter worth about $58,000. American Century Companies Inc. increased its holdings in PetMed Express by 15.3% during the fourth quarter. American Century Companies Inc. now owns 33,662 shares of the company's stock worth $162,000 after buying an additional 4,459 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of PetMed Express by 355.5% during the 4th quarter. JPMorgan Chase & Co. now owns 106,954 shares of the company's stock worth $516,000 after purchasing an additional 83,473 shares during the last quarter. 73.33% of the stock is owned by hedge funds and other institutional investors.

About PetMed Express

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.